Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 3
Submit an article Journal homepage
258
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Mitigation strategies among cutaneous T-cell lymphoma patients with positive Staphylococcus aureus skin and soft tissue cultures have unclear impacts on the risk of subsequent bacteremia

Pamela B. Allena Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3959-3662View further author information
ORCID Icon,
Subir Goyalb Department of Biostatistics & Bioinformatics, Rollins School of Public Heath, Emory University, Atlanta, GA, USAView further author information
,
Jeffrey Switchenkob Department of Biostatistics & Bioinformatics, Rollins School of Public Heath, Emory University, Atlanta, GA, USAView further author information
,
Erica Tarabadkara Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA;c Department of Dermatology, Emory University, Atlanta, GA, USAView further author information
,
Stephanie Pouchd Department of Internal Medicine, Infectious Disease, Emory University, Atlanta, GA, USAView further author information
,
Priya Parikha Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USAView further author information
,
Alex Palmera Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USAView further author information
,
Dylan Martinif Department of Internal Medicine, Massachussettes General Hospital, USAView further author information
,
Esther Kime Undergradute studies, University of Georgia, Athens, GA, USAView further author information
&
Mary Jo Lechowicza Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USAView further author information
 show all
Pages 597-604 | Received 05 Apr 2022, Accepted 14 May 2022, Published online: 07 Jun 2022

References

  • Axelrod PI, Lorber B, Vonderheid EC. Infections complicating mycosis fungoides and Sézary syndrome. JAMA. 1992;267(10):1354–1358.
  • Talpur R, Bassett R, Duvic M. Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome. Br J Dermatol. 2008;159(1):105–112.
  • Nguyen V, Huggins RH, Lertsburapa T, et al. Cutaneous T-cell lymphoma and Staphylococcus aureus colonization. J Am Acad Dermatol. 2008;59(6):949–952.
  • Willerslev-Olsen A, Krejsgaard T, Lindahl LM, et al. Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma. Blood. 2016;127(10):1287–1296.
  • Blumel E, Willerslev-Olsen A, Gluud M, et al. Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma. Oncoimmunology. 2019;8(11):e1641387.
  • Krejsgaard T, Willerslev-Olsen A, Lindahl LM, et al. Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation. Blood. 2014;124(5):761–770.
  • Duvic M. Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndrome. Hematology Am Soc Hematol Educ Program. 2015;2015(1):529–544.
  • Allen PB, Switchenko J, Ayers A, et al. Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL). Leuk Lymphoma. 2020;61(11):2652–2658.
  • Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110(6):1713–1722.
  • Allen PB, Switchenko J, Ayers A, et al. Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL). Leuk Lymphoma. 2020;61:1–7.
  • Kim EJ, Hess S, Richardson SK, et al. Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest. 2005;115(4):798–812.
  • Whittaker S, Hoppe R, Prince HM. How I treat mycosis fungoides and Sézary syndrome. Blood. 2016;127(25):3142–3153.
  • Kim YH, Bagot M, Pinter-Brown L, et al. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Lancet Oncol. 2018;19(9):1192–1204.
  • Lindahl LM, Willerslev-Olsen A, Gjerdrum LMR, et al. Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma. Blood. 2019;134(13):1072–1083.
  • Emge DA, Bassett RL, Duvic M, et al. Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients. Arch Dermatol Res. 2020;312(4):283–288.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.